Author

J. E.

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Aug 2026

Empagliflozin Alleviates Renal Ischemia-Reperfusion Injury by Targeting AMPK/NLRP3 Signaling.

EMPA can effectively improve RIRI by inhibiting inflammation, and its mechanism may be closely associated with inactivation of the NLRP3 inflammasome through the promotion of AMPK activation via phosphorylation modification.

J. E., Jia Wang, Jiong Zhang · Transplantation Proceedings · 0 citations